1d
ScienceAlert on MSNA Shocking Number Still Don't Know The Risk of Taking Aspirin Each DayA new report shows that almost half of the adults in the US aren't aware of the latest health guidelines around aspirin, which claim the risks of a daily low-dose aspirin outweigh the benefits. This ...
3d
Hosted on MSNNew Study: Cholesterol May Affect Dementia Risk by Up to 60%Scientific experts across four continents collaborated to identify an important point in the link between heart and brain ...
AURORA, Colo. -- Among those at low-risk for preterm birth, a blood-based biomarker screening test during the second ...
The only subgroup with a significant difference in outcomes was multifetal pregnancies, though the study was not powered to ...
Aspirin has been shown to effectively reduce recurrence rates and improve disease-free survival,” said Anna Martling, MD, PhD.
After endoscopic documentation of ulcer healing, patients received either clopidogrel (75 mg daily) plus placebo or aspirin (80 mg daily) plus esomeprazole (20 mg twice daily). Patients who tested ...
The patients were randomly assigned to receive placebo or aspirin at 200 mg daily for 3 years ... In the per-protocol cohort, the 5-year DFS rate was 80.3% and 78.6%, respectively (HR, 0.93 ...
Aspirin reduced disease recurrence in patients PI3K-mutated colorectal cancer, underscoring the value of early genomic ...
In both groups, patients were randomly assigned to receive aspirin at 160 mg daily or daily placebo for ... the median age at baseline was 66 (range, 31-80) years, 52% of patients were women ...
aDivision of Hematology and Hematological Malignancies, Department of Medicine, University of Calgary, Calgary, AB, Canada bDepartment of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine ...
Although MG hasn’t revealed exact specifications yet, going by the dimensions of the international-spec D90 Max, the Majestor could measure 5,046mm in length, 2,016mm in width and 1,876mm in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results